HEALTH SECTOR NEWS


MTX to design landmark diagnostics and treatment centre in Wales


MTX Contracts Ltd has been chosen to design a new diagnostics and treatment centre for South East Wales located in Llantrisant, Rhondda Cynon Taf. The project, which will be built using modern methods of construction, will transform the former British Airways Avionics Engineering (BAAE) site near Cardiff into a state-of-the-art healthcare campus, delivering a c.17,300m² new build development across three buildings with supporting infrastructure to create a Community Diagnostics Hub and Treatment Centre.


MTX has been appointed under a


Pre-Construction Services Agreement (PCSA) to deliver Phase 1 of the development, which focuses on the design and construction of the Community Diagnostics Hub. This first phase will cover around 7,500m² and is scheduled to begin construction later this year. Set across three floors, the new


Hartley said: “We are extremely proud to be partnering with the health boards to develop this exciting new facility, which represents a major step forward for healthcare in South East Wales. Combining our healthcare expertise with Modern Methods of Construction, we are developing a design that will deliver an outstanding asset for patients and clinicians alike.” Paul Mears, chief executive of


hub will house a range of advanced diagnostic and treatment facilities. The ground floor will include MRI, CT, ultrasound, and plain film X-ray suites, alongside dedicated endoscopy procedure rooms, follow-up screening, and clinical services. The second floor will accommodate plant rooms and a training area for staff, including an Endoscopy Academy designed to provide a high-quality regional NHS training centre for endoscopists. External landscaping and


supporting works will also form part of this phase, including improvements to existing car parking and roads, as well as compliance landscaping to


IMed Group appoints new manager


IMed Group has appointed Spencer Keegan as talent acquisition manager, as the regulatory consultancy expands its internal capability and develops new recruitment services for clients. Keegan joins IMed’s commercial team with more than 14 years’ experience recruiting within the life sciences sector. He has delivered recruitment projects across Europe, the United States and Asia, and has worked across the medical device, pharmaceutical and clinical research industries. His experience includes leading quality and regulatory-focused recruitment campaigns and


building international networks of compliance professionals. In his new role, Keegan will


oversee IMed Group’s internal talent acquisition strategy and support the development of client-facing recruitment services,


covering permanent and contract appointments. IMed Group provides regulatory consultancy services to the global medical and health technology industry, supporting medical device and in vitro diagnostic manufacturers across the product lifecycle.


Spencer Keegan said: “I’m


tremendously excited to be joining IMed Group as their talent acquisition manager. IMed has built a strong reputation for delivering high-quality expert regulatory services to the global medical and health technology sector, and I’m looking forward to joining a team with such clear vision and purpose. With exciting expansion plans into Europe, I will help drive IMed’s progress and take a major step into the European market.” Parminder Kalle, chief


commercial officer at IMed Group, commented: “We are delighted to welcome Spencer to IMed Group. His extensive experience within the life sciences sector makes him an excellent fit for our organisation.”


the south of the site for SAB design requirements. The Welsh Government has


granted official approval of funding for phase one of the Llantrisant Health Park which will support regional collaboration between Cwm Taf Morgannwg University Health Board, Cardiff and Vale University Health Board, and Aneurin Bevan University Health Board. The facility will improve access to diagnostics and treatment, enhance service delivery, and provide a centre of excellence for high-volume, low-complexity orthopaedic and day/ outpatient general surgery. MTX managing director David


Cwm Taf Morgannwg University Health Board, commented: “Llantrisant Health Park represents an exciting step forward for health care services in South East Wales. By bringing together diagnostic, surgical and specialist services in one purpose-built facility, we can improve access, reduce delays and provide a better experience for patients across the region.” Cabinet Secretary for Health and Social Care Jeremy Miles added: “This investment in Llantrisant Health Park demonstrates our commitment to building an NHS that works for everyone in Wales. By bringing together three health boards to deliver modern diagnostic services closer to where people live, we are taking practical steps to reduce waiting times and improve patient care across South-East Wales.”


Singu acquires UK healthcare software provider


Singu, a European provider of cloud-based software for property and facilities management, has acquired UK-based Synbiotix. The move strengthens Singu’s


presence in the UK and expands its healthcare capabilities, with a focus on supporting operational and regulatory requirements in the NHS. Synbiotix specialises in software


for healthcare facilities management, covering catering, compliance, infection prevention and control (IPC), and audit and governance processes. It says its tools help healthcare


organisations manage regulatory obligations, reduce operational risk, and improve patient safety. The acquisition adds a healthcare- focused layer to Singu’s platform and complements its existing Micad solutions. Following Singu’s acquisition of Micad in 2025, which enhanced its space and asset management capabilities, Synbiotix strengthens the Group’s integrated facilities management offering. Together,


Singu provides the core CAFM and maintenance platform, Micad adds space, compliance, and asset intelligence, and Synbiotix delivers specialist digital tools for healthcare operations. Synbiotix will continue


to operate within the Singu Group, ensuring continuity for existing customers while gaining access to a scalable, cloud-based platform. The integration also opens opportunities to extend Synbiotix’s solutions to the existing Micad customer base, supporting operations across more than 200 NHS Trusts. The acquisition forms part of


Singu’s growth strategy in Europe which it says highlights the strategic importance of healthcare to the Group. Paweł Malon, Group CEO,


said: “The acquisition of Synbiotix significantly strengthens our position in the healthcare market and further establishes Singu as a leading European provider of property operations software.”


March 2026 Health Estate Journal 17


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80